Literature DB >> 23795938

Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis.

K J Psoter1, A J De Roos, J Wakefield, J Mayer, M Rosenfeld.   

Abstract

Pseudomonas aeruginosa, the principal respiratory pathogen in cystic fibrosis (CF) patients, is ubiquitous in the environment. Initial P. aeruginosa isolates in CF patients are generally environmental in nature. However, little information regarding seasonality of P. aeruginosa acquisition is available. We conducted a retrospective study to evaluate the seasonality of initial P. aeruginosa acquisition in young children with CF in the USA using the Cystic Fibrosis Foundation National Patient Registry from 2003 to 2009. Additionally, we assessed whether seasonal acquisition varied by climate zone. A total of 4123 children met inclusion criteria and 45% (n = 1866) acquired P. aeruginosa during a mean 2.0 years (SD 0.2 years) of follow up. Compared with winter, increased P. aeruginosa acquisition was observed in summer (incidence rate ratio (IRR): 1.22; 95% CI: 1.07-1.40) and autumn (IRR: 1.34; 95% CI: 1.18-1.52), with lower acquisition observed in spring (IRR: 0.81; 95% CI: 0.70-0.94). Seasonal variations in P. aeruginosa acquisition rates in the temperate and continental climate zones were similar to those in the overall cohort. In contrast, no significant seasonal effect was observed in the dry climate zone. In a corresponding analysis, no seasonal difference was observed in the rate of acquisition of Staphylococcus aureus, another common CF respiratory pathogen. These results provide preliminary support that climatic factors may be associated with initial P. aeruginosa acquisition in CF patients. Investigation and identification of specific risk factors, as well as awareness of seasonal variation, could potentially inform clinical recommendations including increased awareness of infection control and prevention strategies.
© 2013 The Authors Clinical Microbiology and Infection © 2013 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Acquisition; Pseudomonas aeruginosa; climate; cystic fibrosis; seasonality

Mesh:

Year:  2013        PMID: 23795938     DOI: 10.1111/1469-0691.12272

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  16 in total

1.  Children and young adults with CF in the USA have better lung function compared with the UK.

Authors:  Christopher H Goss; Stephanie J MacNeill; Hebe B Quinton; Bruce C Marshall; Alexander Elbert; Emily A Knapp; Kristofer Petren; Elaine Gunn; Joanne Osmond; Diana Bilton
Journal:  Thorax       Date:  2014-09-25       Impact factor: 9.139

2.  Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.

Authors:  Sally Palser; Sherie Smith; Edward F Nash; Arnav Agarwal; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17

Review 3.  Impact of Climate Change on Eye Diseases and Associated Economical Costs.

Authors:  Lucía Echevarría-Lucas; José Mᵃ Senciales-González; María Eloísa Medialdea-Hurtado; Jesús Rodrigo-Comino
Journal:  Int J Environ Res Public Health       Date:  2021-07-05       Impact factor: 3.390

4.  Air pollution exposure is associated with MRSA acquisition in young U.S. children with cystic fibrosis.

Authors:  Kevin J Psoter; Anneclaire J De Roos; Jon Wakefield; Jonathan D Mayer; Margaret Rosenfeld
Journal:  BMC Pulm Med       Date:  2017-07-27       Impact factor: 3.317

5.  Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.

Authors:  Kevin J Psoter; Anneclaire J De Roos; Jon Wakefield; Jonathan D Mayer; Margaret Rosenfeld
Journal:  BMC Infect Dis       Date:  2017-06-09       Impact factor: 3.090

6.  Nasal microbiota clusters associate with inflammatory response, viral load, and symptom severity in experimental rhinovirus challenge.

Authors:  Markus J Lehtinen; Ashley A Hibberd; Sofia Männikkö; Nicolas Yeung; Tommi Kauko; Sofia Forssten; Liisa Lehtoranta; Sampo J Lahtinen; Buffy Stahl; Anna Lyra; Ronald B Turner
Journal:  Sci Rep       Date:  2018-07-30       Impact factor: 4.379

Review 7.  Influences of environmental exposures on individuals living with cystic fibrosis.

Authors:  Rhonda Szczesniak; Jessica L Rice; Cole Brokamp; Patrick Ryan; Teresa Pestian; Yizhao Ni; Eleni-Rosalina Andrinopoulou; Ruth H Keogh; Emrah Gecili; Rui Huang; John P Clancy; Joseph M Collaco
Journal:  Expert Rev Respir Med       Date:  2020-04-26       Impact factor: 3.772

8.  The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention.

Authors:  Thomas H Hampton; Deanna M Green; Garry R Cutting; Hilary G Morrison; Mitchell L Sogin; Alex H Gifford; Bruce A Stanton; George A O'Toole
Journal:  Microbiome       Date:  2014-04-28       Impact factor: 14.650

9.  Respiratory infection rates differ between geographically distant paediatric cystic fibrosis cohorts.

Authors:  Kathryn A Ramsey; Emily Hart; Lidija Turkovic; Marc Padros-Goossens; Stephen M Stick; Sarath C Ranganathan
Journal:  ERJ Open Res       Date:  2016-09-26

Review 10.  Fatigue in Chronic Respiratory Diseases: Theoretical Framework and Implications For Real-Life Performance and Rehabilitation.

Authors:  Mathieu Gruet
Journal:  Front Physiol       Date:  2018-09-19       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.